Alpha Tau Medical Ltd.
DRTS · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $1 | $1 | $1 | $1 |
| Gross Profit | -$1 | -$1 | -$1 | -$1 |
| % Margin | – | – | – | – |
| R&D Expenses | $27 | $26 | $21 | $11 |
| G&A Expenses | $7 | $7 | $10 | $2 |
| SG&A Expenses | $8 | $9 | $11 | $2 |
| Sales & Mktg Exp. | $1 | $2 | $1 | $0 |
| Other Operating Expenses | $0 | -$1 | $0 | $0 |
| Operating Expenses | $35 | $35 | $32 | $14 |
| Operating Income | -$36 | $36 | -$32 | -$14 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $4 | $7 | -$2 | -$13 |
| Pre-Tax Income | -$32 | -$29 | -$34 | -$27 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$32 | -$29 | -$34 | -$27 |
| % Margin | – | – | – | – |
| EPS | -0.45 | -0.42 | -0.53 | -0.67 |
| % Growth | -7.1% | 20.8% | 20.9% | – |
| EPS Diluted | -0.45 | -0.42 | -0.53 | -0.67 |
| Weighted Avg Shares Out | 70 | 69 | 64 | 41 |
| Weighted Avg Shares Out Dil | 70 | 69 | 64 | 41 |
| Supplemental Information | – | – | – | – |
| Interest Income | $4 | $5 | $2 | $0 |
| Interest Expense | $0 | $0 | $2 | $13 |
| Depreciation & Amortization | $1 | $1 | $1 | $1 |
| EBITDA | -$30 | -$28 | -$33 | -$13 |
| % Margin | – | – | – | – |